Page 148 - IJB-10-1
P. 148

International Journal of Bioprinting                                 Bioprinting organoids for toxicity testing




               function of porcine neonatal pancreatic cell clusters.   57.  Kumar SA, Delgado M, Mendez VE, et al.  Applications
               Xenotransplantation. 2018;25(2):e12378.            of stem cells and bioprinting for potential treatment of
               doi: 10.1111/xen.12378                             diabetes. World J Stem Cells. 2019;11(1):13-32.
                                                                  doi: 10.4252/wjsc.v11.i1.13
            46.  Kim J, Shim IK, Hwang DG, et al. 3D cell printing of islet-
               laden pancreatic tissue-derived extracellular matrix bioink   58.  Di Piazza E, Pandolfi E, Cacciotti I, et al.  Bioprinting
               constructs for enhancing pancreatic functions.  J Mater   technology in skin, heart, pancreas and cartilage tissues:
               Chem B. 2019;7(10):1773-1781.                      Progress and challenges in clinical practice. Int J Environ Res
               doi: 10.1039/c8tb02787k                            Public Health. 2021;18(20):10806.
            47.  Ahn, CB, Lee, JH, et al. Development of a 3D subcutaneous      doi: 10.3390/ijerph182010806
               construct containing insulin-producing beta cells using.   59.  Xu Y, Song D, Wang X. 3D bioprinting for pancreas engineering/
               bioprinting. Bio-des Manuf. 2022;5: 265-276.       manufacturing. Polymers (Basel). 2022;14(23):5143.
               doi: 10.1007/s42242-021-00178-9                    doi: 10.3390/polym14235143
            48.  Lee SJ, Lee JB, Park YW, et al.  3D bioprinting for   60.  Huang B, Wei X, Chen K, et al.  Bioprinting of hydrogel
               artificial pancreas organ.  Adv Exp Med Biol, 2018;1064:    beads to engineer pancreatic tumor-stroma microtissues for
               355-374.                                           drug screening. Int J Bioprint. 2023;9(3):676.
               doi: 10.1007/978-981-13-0445-3_21                  doi: 10.18063/ijb.676
            49.  Wszoła M, Nitarska D, Cywoniuk P, et al. Stem cells as a   61.  Noel P, Muñoz R, Rogers GW, et al. Preparation and metabolic
               source of pancreatic cells for production of 3D bioprinted   assay of 3-dimensional spheroid co-cultures of pancreatic
               bionic pancreas in the treatment of type 1 diabetes. Cells.   cancer cells and fibroblasts. J Vis Exp. 2017;(126):56081.
               2021;10(6):1544.                                   doi: 10.3791/56081
               doi: 10.3390/cells10061544
                                                               62.  Lee H. Engineering in vitro models: Bioprinting of organoids
            50.  Safir F, Vu N, Tadesse LF, et al.  Combining acoustic   with artificial intelligence. Cyborg Bionic Syst. 2023;4: 0018.
               bioprinting with AI-assisted raman spectroscopy for high-     doi: 10.34133/cbsystems.0018
               throughput identification of bacteria in blood.  Nano Lett.
               2023;23(6):2065-2073.                           63.  Shukla P, Yeleswarapu S, Heinrich MA, et al.  Mimicking
               doi: 10.1021/acs.nanolett.2c03015                  tumor microenvironment by 3D bioprinting: 3D cancer
                                                                  modeling. Biofabrication, 2022;14(3).
            51.  Christou CD, Tsoulfas G. Role of three-dimensional      doi: 10.1088/1758-5090/ac6d11
               printing and artificial intelligence in the management of
               hepatocellular  carcinoma:  Challenges  and  opportunities.   64.  Qu J, Kalyani FS, Liu L, et al. Tumor organoids: Synergistic
               World J Gastrointest Oncol. 2022;14(4):765-793.    applications, current challenges, and future prospects in cancer
               doi: 10.4251/wjgo.v14.i4.765                       therapy. Cancer Commun (Lond). 2021;41(12):1331-1353.
                                                                  doi: 10.1002/cac2.12224
            52.  Jiang T, Yang T, Bao Q, et al. Construction of tissue-customized
               hydrogels from cross-linkable materials for effective tissue   65.  Fang L, Liu Y, Qiu J, et al. Bioprinting and its use in tumor-
               regeneration. J Mater Chem B. 2022;10(25):4741-4758.  on-a-chip technology for cancer drug screening: A review.
               doi: 10.1039/d1tb01935j                            Int J Bioprint. 2022;8(4):603.
                                                                  doi: 10.18063/ijb.v8i4.603
            53.  Salg GA, Poisel E, Neulinger-Munoz M, et al.  Toward
               3D-bioprinting of an endocrine pancreas: A building-block   66.  Lin M, Tang M, Duan W, et al. 3D bioprinting for tumor
               concept for bioartificial insulin-secreting tissue. J Tissue Eng.   metastasis research.  ACS Biomater Sci Eng. 2023;9(6):
               2022;13: 20417314221091033.                        3116-3133.
               doi: 10.1177/20417314221091033                     doi: 10.1021/acsbiomaterials.3c00239
            54.  Farina M, Ballerini A, Fraga DW, et al.  3D printed   67.  Das  R,  Fernandez  JG.  Biomaterials  for  Mimicking  and
               vascularized  device  for  subcutaneous  transplantation  of   Modelling Tumor Microenvironment.  Adv Exp Med Biol.
               human islets. Biotechnol J. 2017; 12(9):1700169.   2022;1379:139-170.
               doi: 10.1002/biot.201700169                        doi: 10.1007/978-3-031-04039-9_6
            55.  Hwang DG, Jo Y, Kim M, et al.  A 3D bioprinted hybrid   68.  Tang M, Xie Q, Gimple RC, et al.  Three-dimensional
               encapsulation system for delivery of human pluripotent stem   bioprinted  glioblastoma  microenvironments  model
               cell-derived pancreatic islet-like aggregates. Biofabrication.   cellular dependencies and immune interactions.  Cell Res.
               2021;14(1).                                        2020;30(10):833-853.
               doi: 10.1088/1758-5090/ac23ac                      doi: 10.1038/s41422-020-0338-1
            56.  Ravnic DJ, Leberfinger AN, Ozbolat IT. Bioprinting and   69.  Mi X, Su Z, Yue X, et al. 3D bioprinting tumor models mimic
               cellular therapies for type 1 diabetes.  Trends  Biotechnol.   the tumor microenvironment for drug screening. Biomater
               2017;35(11):1025-1034.                             Sci. 2023;11(11):3813-3827.
               doi: 10.1016/j.tibtech.2017.07.006                 doi: 10.1039/d3bm00159h

            Volume 10 Issue 1 (2024)                       140                          https://doi.org/10.36922/ijb.1256
   143   144   145   146   147   148   149   150   151   152   153